Clinical Trials
2 trialsNCT05251727 2024-08-19
Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients
Veloxis Pharmaceuticals
Phase 1 Terminated
NCT02792842 2024-04-04
Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer
Asahi Kasei Therapeutics Corporation
Phase 2 Completed